newsfilter
← Latest News
Business Wire·

Infinity to Present at 40th Annual J.P. Morgan Healthcare Conference

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, today announced that Adelene Perkins, Chief Executive O